Additionally, MAE improves hepatic insulin resistance through inhibiting PGC-1α and FOXO1 transcriptional activity to decrease gluconeogenesis as well as suppressing JNK phosphorylation to enhance insulin signalling transduction. Here, MAPK8 is linked to Insulin resistance.